Health Care Consumption Due to Atrial Fibrillation is Markedly Reduced by Maze III Surgery

Annals of Thoracic Surgery

Volumn 83, Issue 5, 2007, Pages 1713-1716

  Wierup, Per ^a   Lidén, Hans ^a   Johansson, Birgitta ^a   Nilsson, Michael ^a   Edvardsson, Nils ^a   W O Berglin, Eva ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH CARE; HEALTH ECONOMICS; HEALTH SERVICE; HEART ATRIUM FIBRILLATION; HEART SURGERY; HOSPITAL COST; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; OUTPATIENT; PRIORITY JOURNAL;

ADULT; AGED; ATRIAL FIBRILLATION; CARDIAC SURGICAL PROCEDURES; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 34247278154     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2006.12.038     Document Type: Article

References (15)

1. Cox J.L., Schuessler R.B., D'Agostino Jr. H.J., et al. The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure. J Thorac Cardiovasc Surg 101 (1991) 569-583
2. Kannel W.B., Abbott R.D., Savage D.D., and McNamara P.M. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med 306 (1982) 1018-1022
3. Benjamin E.J., Wolf P.A., D'Agostino R.B., Silbershatz H., Kannel W.B., and Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 98 (1998) 946-952
4. Falk R.H. Atrial fibrillation. N Engl J Med 344 (2001) 1067-1078
5. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 154 (1994) 1449-1457
6. Stewart S., Murphy N., Walker A., McGuire A., and McMurray J.J. Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK. Heart 90 (2004) 286-292
7. Cox J.L., Ad N., Palazzo T., et al. Current status of the Maze procedure for the treatment of atrial fibrillation. Semin Thorac Cardiovasc Surg 12 (2000) 15-19
8. McCarthy P.M., Gillinov A.M., Castle L., Chung M., and Cosgrove III D. The Cox-Maze procedure: the Cleveland Clinic experience. Semin Thorac Cardiovasc Surg 12 (2000) 25-29
9. Schaff H.V., Dearani J.A., Daly R.C., Orszulak T.A., and Danielson G.K. Cox-Maze procedure for atrial fibrillation: Mayo Clinic experience. Semin Thorac Cardiovasc Surg 12 (2000) 30-37
10. Ad N., and Cox J.L. Stroke prevention as an indication for the Maze procedure in the treatment of atrial fibrillation. Semin Thorac Cardiovasc Surg 12 (2000) 56-62
11. Fuster V., Ryden L.E., Asinger R.W., et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Eur Heart J 22 (2001) 1852-1923
12. Cox J.L. The surgical treatment of atri fibrillation. IV. Surgical technique. J Thorac Cardiovasc Surg 101 (1991) 584-592
13. Wolf P.A., Mitchell J.B., Baker C.S., Kannel W.B., and D'Agostino R.B. Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med 158 (1998) 229-234
14. Go A.S., Hylek E.M., Phillips K.A., et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. JAMA 285 (2001) 2370-2375
15. Kopecky S.L., Gersh B.J., McGoon M.D., et al. The natural history of lone atrial fibrillation. A population-based study over three decades. N Engl J Med 317 (1987) 669-674